NDC 66424-995 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66424-995
- Manufacturer
- Contract Pharmacy Services-PA
- Effective date
- 2010-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen - Contract Pharmacy Services-PA | Contract Pharmacy Services-PA | 2010-07-30 | HUMAN OTC DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | IBUPROFEN TABLET [CONTRACT PHARMACY SERVICES-PA] | 1 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | IBUPROFEN TABLET [CONTRACT PHARMACY SERVICES-PA] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IBUPROFEN | IBUPROFEN | DISCOUNT DRUG MART, INC. | d07ea9e3-88b0-4aa0-903a-10555dcca37d | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | DISCOUNT DRUG MART, INC. | aae40114-343e-12da-e053-2a95a90a9213 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | BJWC | 0ca0b6cf-7d1f-4673-b9b9-48f78d80c00a | 2026-06-23 | Warnings | WK2XYI10QM |
| pain relief | IBUPROFEN | Bionpharma Inc. | 2b4ecdd8-627a-445f-8ddc-f2b6c832c1e8 | 2026-06-23 | Warnings | WK2XYI10QM |
| dye-free pain relief | IBUPROFEN | Bionpharma Inc. | c46c9c36-8844-7b50-e053-2a95a90aa0e9 | 2026-06-23 | Warnings | WK2XYI10QM |
| dye-free pain relief | IBUPROFEN | Bionpharma Inc. | 4227d0b7-846a-dcb0-e063-6294a90af7d7 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 3c1c1b65-f57f-62b0-e063-6294a90a1021 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Chain Drug Marketing Association, Inc. | 3802982a-2373-9ca3-e063-6394a90a0ab7 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 4573753d-117b-a6f2-e063-6394a90ae2f9 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Chain Drug Marketing Association, Inc. | 3ed7faff-fd48-0a83-e063-6394a90aab14 | 2026-06-23 | Warnings | WK2XYI10QM |
| Pain Relief | IBUPROFEN | Albertsons Companies | f9deaeb7-efb3-4019-e053-6394a90a33d6 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | MEIJER DISTRIBUTION INC. | bc15fea8-0d86-4546-e053-2995a90abee3 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | MEIJER DISTRIBUTION INC. | a13ac87b-b395-685e-e053-2a95a90ab5d3 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Whole Foods Market, INC. | 32348505-744c-fbfd-e063-6394a90a82d7 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | AMERISOURCE BERGEN | 1afcf0c6-bd41-4621-9e44-d97b81221c12 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | AMERISOURCE BERGEN | a13cee82-1c4e-0cbe-e053-2a95a90a3ab8 | 2026-06-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 51de1183-d226-4869-a00a-f6c74e126a39 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 25a94943-9acc-49c8-a4da-7e07bb2c35eb | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Topco Associates, LLC | 59a88ca7-eb37-46de-9134-a5a6d330bd49 | 2026-06-23 | Warnings | 310965 WK2XYI10QM |
| Ibuprofen Famotidine | IBUPROFEN FAMOTIDINE | Direct_Rx | 54d9e1fc-507d-1859-e063-6394a90a8c6b | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.